Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Cash from Operations (2010 - 2026)

Geron's (GERN) quarterly Cash from Operations came in at -$15.8 million in Q2 2026, up 42.27% year-over-year from -$11.1 million in Q2 2025, and up 74.84% quarter-over-quarter from -$62.9 million in Q1 2026.

Analysis

Geron (GERN) Cash from Operations (2010 - 2026) Analysis & Trends

Geron has disclosed Cash from Operations across 17 years of filings, most recently posting -$15.8 million for Q2 2026.

  • In Q2 2026, Cash from Operations rose 42.27% year-over-year to -$15.8 million; the TTM figure through Jun 2026 stood at -$114.4 million (up 35.85% YoY), while the FY2025 annual figure was -$111.0 million, up 49.21% from the prior year.
  • Cash from Operations came in at -$15.8 million for Q2 2026 at Geron, up from -$62.9 million in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of -$13.6 million in Q3 2025 to a low of -$62.9 million in Q1 2026.
  • Average Cash from Operations over 5 years is -$39.1 million, with a median of -$38.1 million recorded in 2022.
  • Year-over-year, Cash from Operations tumbled 80.66% in 2024 and jumped 76.97% in 2025.
  • Over 5 years, Cash from Operations stood at -$35.2 million in 2022, then retreated by 16.36% to -$40.9 million in 2023, then fell by 7.35% to -$43.9 million in 2024, then jumped by 49.78% to -$22.1 million in 2025, then rose by 28.28% to -$15.8 million in 2026.
  • Per Business Quant data, the three most recent Cash from Operations figures were -$15.8 million in Q2 2026, -$62.9 million in Q1 2026, and -$22.1 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 4.00 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 3.57 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.13 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 813.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -526.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 326.72 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 448.90 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -270.50 Mn
10 Geron 914.60 Mn 613.75 Mn - -15.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.83 Mn
Mar 31, 2026 -62.91 Mn
Dec 31, 2025 -22.07 Mn
Sep 30, 2025 -13.58 Mn
Jun 30, 2025 -27.42 Mn
Mar 31, 2025 -47.98 Mn
Dec 31, 2024 -43.95 Mn
Sep 30, 2024 -58.94 Mn
Jun 30, 2024 -53.48 Mn
Mar 31, 2024 -62.25 Mn
Dec 31, 2023 -40.94 Mn
Sep 30, 2023 -50.84 Mn
Jun 30, 2023 -29.60 Mn
Mar 31, 2023 -46.37 Mn
Dec 31, 2022 -35.18 Mn
Sep 30, 2022 -29.58 Mn
Jun 30, 2022 -28.64 Mn
Mar 31, 2022 -33.97 Mn
Dec 31, 2021 -22.17 Mn
Sep 30, 2021 -22.84 Mn